Unlock instant, AI-driven research and patent intelligence for your innovation.

Indolinone compounds and uses thereof

A technology of compounds and solvates, applied in the field of indolinone compounds and their uses, can solve problems such as toxicity and poor patient condition

Active Publication Date: 2017-08-29
ONCTERNAL THERAPEUTICS INC
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, patients with metastases are still doing poorly, and treatment comes with short- and long-term toxicities

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Indolinone compounds and uses thereof
  • Indolinone compounds and uses thereof
  • Indolinone compounds and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0130] Preparation of Compounds of Formula (I)

[0131]

[0132] Compounds of formula (I) are prepared according to the synthetic schemes set forth herein. In methanol (5 mL), in the presence of diethylamine (10 drops), the ketone of formula (II) (4.0 equivalents) was condensed with the isatin derivative of formula (III) (1.0 equivalents), and the mixture was incubated at room temperature Stir for 24 hours. The reaction mixture was concentrated and purified by flash chromatography using dichloromethane / methanol as eluent to give pure product. Further purification was performed by recrystallization from methanol. The substituents on the ketones and on the isatin derivatives are chosen to give compounds of formula (I) labeled as Example 1 to Example 23 below. To the compound of embodiment 1 to embodiment 26 thus obtained, use Varian-400 spectrometer (400MHz) to record 1 H NMR spectrum. Chemical shifts are given in ppm downfield with tetramethylsilane as an internal sta...

Embodiment 2

[0150]

[0151] To a solution of 4,7-dichloroindole-2,3-dione (A) (300 mg, 1.39 mmol) in 15 mL of methanol was added 1-(4-((aziridine-1-yl)phenyl) Ethanone (B) (0.9g, 5.5mmol) and 10 drops of diethylamine (2). The reactant was stirred at 50°C for 24 hours. The solvent was removed, and the residue was subjected to flash chromatography (0-5% methanol / CH 2 Cl 2 ) to obtain off-white solid. 3-(2-(4-(aziridine-1-yl)phenyl)-2-oxoethyl)-4,7-dichloro-3-oxindol-2-one (Example 2 ): off-white solid; 1 H NMR (DMSO-d6, 400MHz) δ2.16(s, 4H), 3.64(d, 1H, J=16Hz), 4.32(d, 1H, J=16Hz), 6.41(s, 1H), 6.89(d , 1H, J=8Hz), 7.05(d, 2H, J=8Hz), 7.30(d, 1H, J=8Hz), 7.80(d, 2H, J=8Hz), 10.95(s, 1H).

[0152] 4,7-dichloro-3-hydroxy-3-(2-(4-isopropylphenyl)-2-oxoethyl)indol-2-one (Example 3): off-white solid; 1 H NMR (DMSO-d6, 400MHz) δ1.21(d, 6H, J=4Hz), 2.95(m, 1H), 3.69(d, 1H, J=16Hz), 4.39(d, 1H, J=16Hz) , 6.45(s, 1H), 6.90(d, 1H, J=8Hz), 7.29(d, 1H, J=8Hz), 7.38(d, 2H, J=8Hz), 7.85(d, 2H...

Embodiment 7

[0155]

[0156] 1-(4-Cyclopropylphenyl)ethanone (B) (0.9 g , 5.5mmol) and 10 drops of diethylamine (2). The reaction was stirred at 50°C for 24 hours. The solvent was removed and the residue was subjected to flash chromatography (0-5% methanol / CH 2 Cl 2 ) to obtain off-white solid. 4,7-dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-oxindol-2-one (Example 7): off-white solid; 1 H NMR (DMSO-d6, 400MHz) δ0.76(m, 2H), 1.06(m, 2H), 2.0(m, 1H), 3.65(d, 1H, J=16Hz), 4.35(d, 1H, J =16Hz), 6.43(s, 1H), 6.89(d, 1H, J=8Hz), 7.19(d, 2H, J=8Hz), 7.30(d, 1H, J=8Hz), 7.79(d, 2H, J=8Hz), 10.97(s, 1H).

[0157] 3-(2-(4-(1H-pyrazol-1-yl)phenyl)-2-oxoethyl)-4,7-dichloro-3-oxindol-2-one (Example 8 ): off-white solid; 1 H NMR (DMSO-d6, 400MHz) δ3.72(d, 1H, J=16Hz), 4.41(d, 1H, J=16Hz), 6.47(s, 1H), 6.62(d, 1H, J=4Hz) , 6.90(d, 1H, J=8Hz), 7.31(d, 1H, J=8Hz), 7.84(d, 1H, J=4H), 7.99(d, 2H, J=8Hz), 8.06(d, 2H , J=8Hz), 8.66(d, 1H, J=4Hz), 10.98(s, 1H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

Indolinone derivative compounds that act as EWS-FLll transcription factor inhibitors are provided. Also provided are pharmaceutical compositions of the indolinone derivatives, methods of synthesizing the same, methods of treating using same, and assays for identifying the inhibitors of EWS-FLll oncoprotein.

Description

[0001] related application [0002] This application claims the benefit of US Provisional Application No. 62 / 062086, filed October 9, 2014, entitled "INDOLINE COMPOUNDS AND USESTHEREOF," which is incorporated herein by reference in its entirety. technical field [0003] Indolinone derivative compounds useful as EWS-FLI1 transcription factor inhibitors are provided. Also provided are pharmaceutical compositions of indolinone derivatives, methods of synthesizing them, methods of treatment using them, and assays for identifying inhibitors of the EWS-FLI1 oncoprotein. Background technique [0004] The EWS-FLI transcription factor present in various tumors of the Ewing sarcoma family (ESFT) was characterized more than a decade ago. Advances in the treatment of Ewing's sarcoma, the second most common bone tumor in children and adolescents, have improved survival for patients with localized tumors. However, metastatic patients are still doing poorly, and treatment carries short-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/10C07D209/38C07D401/06C07D401/10A61K31/5377A61K31/4439A61K31/404A61K31/4155A61P35/00
CPCC07D209/38C07D401/06C07D401/10C07D403/10A61K31/404A61K31/4155A61K31/4439A61K31/5377C07D209/34A61P11/00A61P15/00A61P17/00A61P19/00A61P21/00A61P25/00A61P35/00A61P35/02A61P43/00A61P7/00
Inventor 尚-米歇尔·维尼尔
Owner ONCTERNAL THERAPEUTICS INC